^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CA9hu-1

    i
    Other names: CA9hu-1
    Associations

    News

    Trials
    Company:
    Mabpro
    Drug class:
    Carbonic anhydrase IX inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    CAMP1: Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours (clinicaltrials.gov)
    P1, N=50, Not yet recruiting, Mabpro, a.s. | Trial completion date: Jan 2026 --> Jan 2027 | Initiation date: Jan 2023 --> Jan 2024 | Trial primary completion date: Jan 2025 --> Jan 2026
    Trial completion date • Trial initiation date • Trial primary completion date • Metastases
    |
    CA9 (Carbonic anhydrase 9)
    |
    CA9hu-1
    over1year
    CAMP1: Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours (clinicaltrials.gov)
    P1, N=50, Not yet recruiting, Mabpro, a.s.
    New P1 trial • Metastases
    |
    CA9 (Carbonic anhydrase 9)
    |
    CA9hu-1